Table 3 Medical characteristics of the sample
| Â | Number (%) |
|---|---|
BMI | Â |
  Underweight (BMI <18) | 7 (1%) |
  Health weight (BMI 19–25) | 235 (48%) |
  Overweight (BMI 26–29) | 120 (25%) |
  Obese (BMI ≥30) | 125 (26%) |
Menopause status 1 | Â |
  Pre-menopausal | 45 (10%) |
  Peri-menopausal | 56 (13%) |
  Post-menopausal | 277 (64%) |
  Patient unsure | 53 (12%) |
Time since last menstrual period 2 | Â |
  <5 years | 76 (23%) |
  5-10 years | 72 (22%) |
  >10 years | 185 (56%) |
Previous HRT use | Â |
  Yes | 144 (33%) |
Musculoskeletal diagnosis at baseline 3 | Â |
  Osteoarthritis | 73 (14%) |
  Rheumatoid arthritis | 16 (3%) |
  Fibromyalgia | 7 (1%) |
  Other arthritis | 33 (6%) |
Taking other medications known to cause joint pain | Â |
(ace inhibitors, proton pump inhibitors, quinolones, tibolones, zoledronic acid, bisphosphonates, angiotensin-II receptor antagonists, etc.) | |
  Yes | 105 (20%) |
Osteo-enhancing supplements 3 | Â |
  Vitamin D | 16 (3%) |
  Calcium | 45 (8%) |
  Glucosamine | 55 (10%) |